Integrated care model and point of care diagnostics facilitate Hepatitis C treatment among patients receiving opioid agonist therapy: a retrospective review of medical records

BACKGROUND: Hepatitis C virus (HCV) is common among individuals in opioid agonist therapy (OAT). HCV treatment has previously been unavailable for most HCV positive OAT patients in Finland. The removal of treatment restrictions and attempts to reach HCV elimination goals have increased the number of...

Descripción completa

Detalles Bibliográficos
Autores principales: Häkkinen, Margareeta, Tourunen, Jouni, Pitkänen, Tuuli, Simojoki, Kaarlo, Vuoti, Sauli
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161480/
https://www.ncbi.nlm.nih.gov/pubmed/35655277
http://dx.doi.org/10.1186/s13011-022-00473-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9161480/
https://www.ncbi.nlm.nih.gov/pubmed/35655277
http://dx.doi.org/10.1186/s13011-022-00473-3

Ejemplares similares